Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuMAST: Minocycline for Acute Stroke Recovery
NCT00930020Phase 4Terminated
- Sponsor
- SingHealth Foundation
- Start
- Jul 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Oral minocycline with Placebo (2 arms). Primary endpoint: modified Rankin Scale at 90 days. Started Jul 2009; status: terminated.
02
Drugs
minocycline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00930020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930020.